Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome

Blood

Volumn 117, Issue 6, 2011, Pages

  Darghouth, Dhouha ^a,b,c,d   Koehl, Bérengère ^a,b,c,d   Madalinski, Geoffrey ^e   Heilier, Jean François ^e,f   Bovee, Petra ^g   Xu, Ying ^c   Olivier, Marie Françoise ^a   Bartolucci, Pablo ^h,i   Benkerrou, Malika ^j   Pissard, Serge ⁱ   Colin, Yves ^h   Galacteros, Frederic ⁱ   Bosman, Giel ^g   Junot, Christophe ^e   Roméo, Paul Henri ^a,b,c,d  

^a INSTITUT DE RADIOBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Institut National de la Recherche Agronomique   (France)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIOXOGULONIC ACID; ARGININE; ASCORBIC ACID; CITRULLINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; NITRIC OXIDE; SPERMIDINE; SPERMINE;

ADULT; ARTICLE; ASCORBIC ACID METABOLISM; CLINICAL ARTICLE; ERYTHROCYTE; EXTRACTION; FEMALE; GLYCOLYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEMBRANE TRANSPORT; METABOLOME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SICKLE CELL ANEMIA; TURNOVER TIME;

EID: 79951491799     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-299636     Document Type: Article

References (50)

1. Nicholson JK. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol. 2006;2:52.
2. Winder CL, Dunn WB, Schuler S, et al. Global metabolic profiling of Escherichia coli cultures: an evaluation of methods for quenching and extraction of intracellular metabolites. Anal Chem. 2008;80(8):2939-2948. (Pubitemid 351556459)
3. Lawton KA, Berger A, Mitchell M, et al. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9(4):383-397. (Pubitemid 351803924)
4. Kind T, Tolstikov V, Fiehn O, Weiss RH. A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem. 2007;363(2): 185-195. (Pubitemid 46428214)
5. Sreekumar A, Poisson LM, Rajendiran TM, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457(7231):910-914.
6. Ritchie SA, Ahiahonu PW, Jayasinghe D, et al. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010;8:13.
7. Oresic M, Simell S, Sysi-Aho M, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008;205(13): 2975-2984.
8. Lewis GD, Wei R, Liu E, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest. 2008;118(10): 3503-3512.
9. Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005;112(25):3868-3875. (Pubitemid 43739484)
10. Shaham O, Slate NG, Goldberger O, et al. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A. 2010;107(4):1571-1575.
11. Joshi A, Palsson BO. Metabolic dynamics in the human red cell: IV. Data prediction and some model computations. J Theor Biol. 1990;142(1): 69-85. (Pubitemid 20040660)
12. van WR, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005;106(13):4034-4042.
13. Roux-Dalvai F, Gonzalez de PA, Simo C, et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics. 2008;7(11):2254-2269.
14. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442):1343- 1360. (Pubitemid 39335827)
15. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med. 2008;44(8):1506-1528.
16. Hankins J, Aygun B. Pharmacotherapy in sickle cell disease: state of the art and future prospects. Br J Haematol. 2009;145(3):296-308.
17. Nishino T, Yachie-Kinoshita A, Hirayama A, Soga T, Suematsu M, Tomita M. In silico modeling and metabolome analysis of long-stored erythrocytes to improve blood storage methods. J Biotechnol. 2009; 144(3):212-223.
18. Darghouth D, Koehl B, Junot C, Romeo PH. Metabolomic analysis of normal and sickle cell erythrocytes. Transfus Clin Biol. 2010;17(3):148-150.
19. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779-787. (Pubitemid 43228585)
20. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6(2):469-479. (Pubitemid 46340151)
21. Tautenhahn R, Bottcher C, Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics. 2008;9:504.
22. Croixmarie V, Umbdenstock T, Cloarec O, et al. Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/ mass spectrometry metabonomic profiles using human hepatocyte cultures. Anal Chem. 2009;81(15):6061-6069.
23. Mei H, Hsieh Y, Nardo C, et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun Mass Spectrom. 2003;17(1):97-103. (Pubitemid 36019888)
24. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007;3(3):211-221.
25. Lelkens CC, Noorman F, Koning JG, et al. Stability after thawing of RBCs frozen with the high-and low-glycerol method. Transfusion. 2003; 43(2):157-164. (Pubitemid 36207294)
26. Sasaki R, Ikura K, Narita H, Yanagawa S, Chiba H. 2,3-Bisphosphoglycerate in erythroid cells. Trends Biochem Sci. 1982;7(4):140-142.
27. Kim PS, Iyer RK, Lu KV, et al. Expression of the liver form of arginase in erythrocytes. Mol Genet Metab. 2002;76(2):100-110. (Pubitemid 34757133)
28. Tunnicliff G. Amino acid transport by human erythrocyte membranes. Comp Biochem Physiol Comp Physiol. 1994;108(4):471-478. (Pubitemid 24222917)
29. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000; 28(1):27-30. (Pubitemid 30047706)
30. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol. 2003; 10(2):99-107. (Pubitemid 36207963)
31. Christensen HN. Interorgan amino acid nutrition. Physiol Rev. 1982;62(4):1193-1233.
32. Jiao Y, Okumiya T, Saibara T, et al. An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time. Clin Biochem. 1998;31(2): 59-65. (Pubitemid 28249129)
33. Jiao YF, Okumiya T, Saibara T, Kudo Y, Sugiura T. Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis. Clin Biochem. 2001; 34(5):395-398. (Pubitemid 32777849)
34. Bosch FH,Werre JM, Roerdinkholder-Stoelwinder B, Huls TH, Willekens FL, Halie MR. Characteristics of red blood cell populations fractionated with a combination of counterflow centrifugation and Percoll separation. Blood. 1992;79(1):254-260.
35. Poillon WN, Kim BC, Castro O. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia. Blood. 1998;91(5):1777-1783. (Pubitemid 28110345)
36. Poillon WN, Kim BC, Labotka RJ, Hicks CU, Kark JA. Antisickling effects of 2,3-diphosphoglycerate depletion. Blood. 1995;85(11):3289-3296.
37. Sana TR, Waddell K, Fischer SM. A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;871(2):314-321.
38. Xu F, Zou L, Lin Q, Ong CN. Use of liquid chromatography/ tandem mass spectrometry and online databases for identification of phosphocholines and lysophosphatidylcholines in human red blood cells. Rapid Commun Mass Spectrom. 2009;23(19):3243-3254.
39. Reid M, Badaloo A, Forrester T, Jahoor F. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab. 2006;291(1):E73-E79. (Pubitemid 44035311)
40. Kiessling K, Roberts N, Gibson JS, Ellory JC. A comparison in normal individuals and sickle cell patients of reduced glutathione precursors and their transport between plasma and red cells. Hematol J. 2000;1(4):243-249.
41. Rabilloud T, Heller M, Gasnier F, et al. Proteomics analysis of cellular response to oxidative stress: evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem. 2002;277(22): 19396-19401. (Pubitemid 34967447)
42. May JM. Ascorbate function and metabolism in the human erythrocyte. Front Biosci. 1998;3:d1-d10.
43. May JM, Qu ZC, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radic Biol Med. 1996;20(4):543-551. (Pubitemid 26097271)
44. May JM. Is ascorbic acid an antioxidant for the plasma membrane? FASEB J. 1999;13(9):995-1006.
45. Test ST, Woolworth VS. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood. 1994;83(3):842-852. (Pubitemid 24043748)
46. Hagar W, Vichinsky E. Advances in clinical research in sickle cell disease. Br J Haematol. 2008;141(3):346-356. (Pubitemid 351521154)
47. Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem. 1992;267(18):12673-12681.
48. Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG, Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol. 2009;145(4): 506-513.
49. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81-90. (Pubitemid 41002842)
50. Morris SM Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr. 2002;22:87-105.